Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment Led by Blue Venture Fund, new funding will accelerate Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes  OXFORD, ENGLAND–– AUG. 16, 2021 –– Read More